Frank Bergman – The Food and Drug Administration (FDA) is preparing to authorize the latest COVID-19 booster shots, developed for the Omicron variant, without first running trials on humans.
Instead, the vaccines will rely on testing on mice and will be approved for public use months before human trials are complete.
The new Omicron shots will be approved by the FDA this week, the Wall Street Journal reported. Continue reading